Tender Details

Country: Japan
Summary: A Abatacept (Genetical Recombination) (250Mg/Vial) 600 Vials,And 42 other Contracts
JPT Ref No: 49344716
Deadline: 12 Mar 2021
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.:
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
A Abatacept (Genetical Recombination) (250mg/vial) 600 vials,and 42 other contracts
Classification :
0004 Medical & Pharmaceutical Products
Summay of Notice :
⑴ Official in charge of disbursement of the procuring entity : Tatsuo Ushiki, President, National University Corporation Niigata University
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased :
A Abatacept (Genetical Recombination) (250mg/vial) 600 vials
B Pembrolizumab (Genetical Recombination) (100mg 4mL/vial) 1,100 vials
C Letermovir (240mg 14tablets/case) 100 cases
D Durvalumab (Genetical Recombination) (120mg 2.4mL/vial) 300 vials
E Durvalumab (Genetical Recombination) (500mg 10mL/vial) 200 vials
F Benralizumab (Genetical Recombination) (30mg 1mL/syringe) 100 syringes
G Olaparib (150mg 56tablets/case) 200 cases
H Palivizumab (Genetical Recombination) (100mg 1mL/vial) 400 vials
I Asfotase alfa (Genetical Recombination) (40mg 1mL/vial) 100 vials
J Asfotase alfa (Genetical Recombination) (80mg 0.8mL/vial) 200 vials
K Eculizumab (Genetical Recombination) (300mg 30mL/vial) 100 vials
L Ravulizumab (Genetical Recombination) (300mg 30mL/vial) 100 vials
M Adalimumab (Genetical Recombination) (40mg 0.4mL/syringe) 1,000 syringes
N Bictegravir sodium Emtricitabine Tenofovir alafenamide fumarate (30tablets/vial) 200 vials
O Eftrenonacog Alfa (Genetical Recombinatio...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

A Abatacept (Genetical Recombination) (250Mg/Vial) 600 Vials,And 42 other Contracts - Japan Tender

The NATIONAL UNIVERSITY CORPORATION, a Government sector organization in Japan, has announced a new tender for A Abatacept (Genetical Recombination) (250Mg/Vial) 600 Vials,And 42 other Contracts. This tender is published on JapanTenders under JPT Ref No: 49344716 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2021-03-12.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.